Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
69°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
CNS Pharmaceuticals, Inc. - Common Stock
(NQ:
CNSP
)
8.820
+0.230 (+2.68%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 25, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about CNS Pharmaceuticals, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
20
21
Next >
12 Health Care Stocks Moving In Monday's Pre-Market Session
January 06, 2025
Via
Benzinga
Research Shows Brain Tumors Grow by Hijacking Circadian Clocks
December 17, 2024
Via
Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Host Virtual Analyst & Investor Day on December 11
December 05, 2024
Via
Investor Brand Network
CNS Pharmaceuticals to Host Virtual Analyst & Investor Day on December 11, 2024
December 05, 2024
Via
ACCESSWIRE
AI Model Promises New Way to Detect Brain Malignancies
December 02, 2024
Via
Investor Brand Network
Topics
Artificial Intelligence
Death
CNS Pharmaceuticals Reports Third Quarter 2024 Financial Results
November 15, 2024
Via
ACCESSWIRE
New Graphene Chip Could Revolutionize Brain Cancer Treatment
November 08, 2024
Via
Investor Brand Network
CNS Pharmaceuticals Announces Virtual Investor KOL Connect Segment
November 04, 2024
Via
ACCESSWIRE
BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Presents Progress in Pivotal Study of Berubicin for Glioblastoma Treatment
November 25, 2024
Via
Investor Brand Network
CNS Pharmaceuticals Presents Update from Ongoing Potentially Pivotal Study of Berubicin Compared with Lomustine in Adult Patients with Recurrent GBM (WHO Grade IV) After Failure of Standard First Line Therapy
November 25, 2024
Via
ACCESSWIRE
BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Present Berubicin Trial Update at Society for Neuro-Oncology Annual Meeting
November 18, 2024
Via
Investor Brand Network
CNS Pharmaceuticals Announces Abstract Accepted for Poster Presentation at the 29th Annual Meeting of the Society for Neuro-Oncology (SNO 2024)
November 18, 2024
Via
ACCESSWIRE
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Advances Glioblastoma Treatment with Berubicin Amid Strong Financial Position
November 15, 2024
Via
Investor Brand Network
BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Highlights Berubicin’s Potential in Glioblastoma Treatment During KOL Connect Event
November 04, 2024
Via
Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Granted Nasdaq Extension for Compliance
November 01, 2024
Via
Investor Brand Network
CNS Pharmaceuticals Granted Exception by Nasdaq to Regain Compliance with Minimum Bid Price Requirement
November 01, 2024
Via
ACCESSWIRE
Stocks Under Ten Cents to Watch in October 2024 CNSP, QLGN, AKTS, CBDW, RJDG
October 25, 2024
Via
AB Newswire
BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Secures $3 Million in Registered Direct Offering
October 24, 2024
Via
Investor Brand Network
12 Health Care Stocks Moving In Thursday's Pre-Market Session
October 24, 2024
Via
Benzinga
Why Tesla Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
October 24, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
October 23, 2024
Via
Benzinga
Nasdaq Down 2%; US Crude Stocks Increase
October 23, 2024
Via
Benzinga
Gold Moves Lower; AT&T Earnings Top Views
October 23, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
October 23, 2024
Via
Benzinga
CNS Pharmaceuticals Announces Pricing of $3 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
October 23, 2024
Via
ACCESSWIRE
Why CNS Pharmaceuticals (CNSP) Stock Is Up 86%
October 23, 2024
CNS Pharmaceuticals shares are trading higher by 76% Wednesday morning. The stock faces potential delisting for not meeting Nasdaq's $1.00 bid price.
Via
Benzinga
Dow Tumbles Over 250 Points; Boeing Posts Q3 Loss
October 23, 2024
Via
Benzinga
Topics
Stocks
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
October 23, 2024
Via
Benzinga
Why Stride Shares Are Trading Higher By Over 24%; Here Are 20 Stocks Moving Premarket
October 23, 2024
Via
Benzinga
BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Management, Dr. Samuel Goldlust Participate in Virtual Investor KOL Connect Segment
October 10, 2024
Via
Investor Brand Network
< Previous
1
2
3
4
5
6
7
8
9
...
20
21
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.
